1820 McCarthy Blvd.
Milpitas
CA
95035
USA
408.273.3700
Cordis, a Cardinal Health company, is a worldwide leader in the development and manufacture of interventional vascular technology with a more than 50-year history of delivering pioneering products to treat millions of patients.
Related Content
December 7, 2023 β The U.S. Food and Drug Administration (FDA) announced Cordis US Corp is recalling its INFINITI ...
December 07, 2023
October 18, 2022 β Swiss-based medical technology company MedAlliance has announced it has entered into an agreement ...
October 18, 2022
March 12, 2021 β Cardinal Health today announced that it is selling its Cordis cardiology and endovascular business to ...
March 12, 2021
May 15, 2019 β Cordis, a Cardinal Health company, recently announced the full U.S. launch of its Radial 360 portfolio ...
May 15, 2019November 2, 2018 β Cordis, a Cardinal Health company, today announced the U.S. launch of Mynx Control Vascular Closure ...
November 05, 2018
February 19, 2018 β The Detroit Medical Centerβs (DMC) interventional cardiology team at Heart Hospital recently became ...
February 19, 2018
Feature | Vascular Closure Devices| Dave Fornell
While manual compression remains the gold standard for hemostasis of catheterization vascular access site arteriotomies ...
January 22, 2018
January 2, 2018 β Osborne & Associates Law Firm, P.A., of Boca Raton, Fla., has filed suit in Palm Beach Circuit Court ...
January 02, 2018
December 13, 2017 β Cordis, a Cardinal Health company, and Medinol recently announced U.S. Food and Drug Administration ...
December 13, 2017
November 10, 2017 β Cordis, a Cardinal Health company, recently unveiled a comprehensive interventional cardiology ...
November 10, 2017Β© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now